Scholars Central

Conference abstractPublished 2018

Nanotechnology may provide new hope for brain cancer therapy

Authors: Alain L Fymat

International Institute of Medicine and Science, USA

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Cancer cells are notoriously resistant to drugs intended to kill them by re-routing the signaling networks responsible for cancer cells growth, proliferation and survival. A drug may block a signaling pathway but within a matter of days (minutes in some cases), cancer cells begin to rely on alternate pathways to promote their survival. The simultaneous use of several drugs (rational combination therapy) is meant to attack both the primary and alternate pathways to pre-emptively block the cancer cells escape route. Unfortunately, the efficacy of many combination therapies has been limited because drugs have very different chemical properties, which cause them to travel to different parts of the body and enter cancer cells at different rates. The situation is considerably more complicated for brain cancer (glioblastoma multiform or octopus tumor) because the cancer cells extend their tendrils into the surrounding tissue, which is virtually inoperable, resistant to therapies and always fatal. A major obstacle to treatment is the blood brain barrier or network of blood vessels that allows essential nutrients to enter the brain but block the passage of other substances. The discussion is on the novel nanotechnology approaches for delivering drugs across and around the brain protective barriers.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Nanomaterials & Molecular Nanotechnology.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Nanomaterials & Molecular Nanotechnology
  • SubjectNanotechnology
  • SubjectGenetics & Molecular Biology
  • BylineArticles whose byline prints “Alain L Fymat”